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Summary
Acquired protection from Plasmodium falciparum
malaria takes years to develop, probably reflecting
the ability of the parasites to evade immunity.
A recent example of this is the binding of the
Fc region of IgM to VAR2CSA-type PfEMP1.
This interferes with specific IgG recognition and
phagocytosis of opsonized infected erythrocytes
(IEs) without compromising the placental IE adhe-
sion mediated by this PfEMP1 type. IgM also binds
via Fc to several other PfEMP1 proteins, where it
has been proposed to facilitate rosetting (binding
of uninfected erythrocytes to a central IE). To
further dissect the functional role of Fc-mediated
IgM binding to PfEMP1, we studied the PfEMP1
protein HB3VAR06, which mediates rosetting and
binds IgM. Binding of IgM to this PfEMP1 involved
the Fc domains Cμ3-Cμ4 in IgM and the penultimate
DBL domain (DBLζ2) at the C-terminus of
HB3VAR06. However, IgM binding did not inhibit
specific IgG labelling of HB3VAR06 or shield IgG-
opsonized IEs from phagocytosis. Instead, IgM
was required for rosetting, and each pentameric
IgM molecule could bind two HB3VAR06 mol-
ecules. Together, our data indicate that the primary
function of Fc-mediated IgM binding in rosetting is
not to shield IE from specific IgG recognition
and phagocytosis as in VAR2CSA-type PfEMP1.
Rather, the function appears to be strengthening of
IE–erythrocyte interactions. In conclusion, our
study provides new evidence on the molecular
details and functional significance of rosetting, a
long-recognized marker of parasites that cause
severe P. falciparum malaria.
Introduction
Most Plasmodium falciparum infections in areas of stable
parasite transmission produce only relatively mild symp-
toms or are asymptomatic. Nevertheless, about 600 000
people, mainly children, die from severe malaria compli-
cations annually (World Health Organization, 2013). It is
not well understood why life-threatening complications
only develop in a minority of infections (Greenwood et al.,
1991). A recent large-scale study underscores the lack of
clear relationships among parasite burden, number of
previous episodes and disease severity (Goncalves et al.,
2014). The marked concentration of severe and fatal
malaria among young children is evidence that protective
immunity can be acquired following natural exposure.
However, even in areas of intense transmission of
P. falciparum parasites clinical immunity takes years and
often many disease episodes to develop, and protection is
rarely if ever sterile. This piecemeal acquisition of protec-
tion appears to depend on gradual accumulation of IgG
with specificity for a broad repertoire of variant antigens
expressed on the infected erythrocyte (IE) surface (Marsh
and Howard, 1986; Bull et al., 1998). Prominent among
these is PfEMP1, a group of antigenically diverse high-
molecular weight proteins composed of modular DBL and
CIDR domains, encoded by the var multi-gene family that
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cellular microbiology
has about 60 members per parasite genome (Leech
et al., 1984; Baruch et al., 1995; Smith et al., 1995; Su
et al., 1995; Gardner et al., 2002). The PfEMP1 proteins
are expressed on the IE surface knob protrusions and
have affinity for host receptors in the vasculature
(Baruch et al., 1995; Smith et al., 1995; Su et al., 1995).
PfEMP1 expression allows IEs to sequester in various
organs to avoid being cleared by the spleen (David
et al., 1988). Development of severe disease is related
to adhesion of IEs to particular receptors mediated by
specific subsets of PfEMP1 proteins (Jensen et al.,
2004; Salanti et al., 2004; Avril et al., 2012; Claessens
et al., 2012; Lavstsen et al., 2012; Turner et al., 2013).
An example is rosetting, which occurs when multiple
uninfected erythrocytes bind to an IE forming aggregates
that can impede the blood flow in vital organs. Rosetting
has long been recognized but remains an incompletely
understood IE adhesion phenotype that has been asso-
ciated with malaria severity in some but not all studies
(Carlson et al., 1990; Treutiger et al., 1992; Rowe et al.,
1995; Kun et al., 1998). Many PfEMP1 proteins and a
range of erythrocyte surface receptors have been impli-
cated in this multifaceted phenotype, which can also
involve additional, soluble components (reviewed by
Mercereau-Puijalon et al., 2008). Binding of IgM to IEs
correlates with rosetting (Rowe et al., 2002), although
IgM may be required, optional or irrelevant in the forma-
tion of various types of rosettes (Scholander et al., 1996;
1998; Clough et al., 1998; Vigan-Womas et al., 2007; Le
et al., 2008). In IgM-dependent rosetting, only the
pentameric form of IgM can facilitate the interaction
between IEs and surrounding erythrocytes (Scholander
et al., 1996). The interaction between IgM and PfEMP1
involves the Fc rather than the Fab domains of IgM
(Ghumra et al., 2008), and the role of IgM in rosetting
therefore does not depend on its antigen specificity.
Although a correlation between rosetting and IgM
binding is undisputed, exactly what role IgM plays in for-
mation of rosettes is unclear. It has been proposed that
IgM (and other serum factors) can act as ‘bridges’
between the IE and the surrounding erythrocytes,
and IgM-containing fibrillar strands have indeed been
observed at apposed IE and erythrocyte membranes
(Scholander et al., 1996). Alternatively, Fc-mediated IgM
binding might serve an immune-evasive function similar
to that reported by us for the VAR2CSA-type PfEMP1,
which bind IgM but do not mediate rosetting (Creasey
et al., 2003; Rasti et al., 2006; Barfod et al., 2011). The
present study was designed to clarify the mechanism
and functional significance of IgM in PfEMP1-mediated
rosetting.
Results
Recombinant HB3VAR06 constructs and
P. falciparum-IE selected for surface expression
of HB3VAR06
All recombinant HB3VAR06 constructs (overview in
Fig. 1A) were secreted into supernatants predominantly
Fig. 1. Recombinant HB3VAR06 constructs. Schematic representation of HB3VAR06 showing individual DBL and CIDR domains (domain start
and end boundaries given above and below individual domains), named and colour coded as proposed by Rask et al. (2010) (A). Coomassie
stain of an SDS-PAGE with recombinant HB3VAR06 constructs under non-reducing (+) and reducing (−) conditions (B and C).
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as soluble monomers. In SDS-PAGE, a shift in mobility
was seen for all constructs following reduction, suggest-
ing the presence of disulfide bonds in these cysteine-
rich proteins (Fig. 1B–C). P. falciparum HB3-IEs selected
in vitro for rosetting and IE surface expression of
HB3VAR06 formed rosettes (Fig. 2A) and were labelled
by all HB3VAR06-specific antisera (Fig. 2B–J). Tran-
scription analysis showed that hb3var06 was the main
var gene transcribed (93% of total var transcription)
(Fig. 2K). No other single var gene accounted for more
than 2% of total var gene transcription. Thus, our recom-
binant proteins, antisera and parasites had the expected
characteristics; were specific; and were suitable for the
present study.
The binding of non-specific IgM to HB3VAR06
All HB3VAR06+ IEs bound non-specific IgM (Fig. 3A) in
agreement with an earlier report (Ghumra et al., 2012).
Recombinant full-length HB3VAR06 (FV6) and recombi-
nant full-length IT4VAR04 (a VAR2CSA-type PfEMP1;
FV2) both efficiently bound non-specific IgM in enzyme-
linked immunosorbent assay (ELISA) in contrast to a
third recombinant full-length PfEMP1 (IT4VAR13; FV13),
which mediates IE adhesion to ICAM-1 and does not
mediate rosette formation (Fig. 3B). The affinity of FV6
and FV2 for non-specific IgM were both found by
surface plasmon resonance (SPR) to be in the low
nanomolar range (KD = 0.1 and 0.3 nM, respectively),
with rapid association (ka = 2.3 × 106 and 1.8 × 106
M–1 s–1) and slow dissociation kinetics (kd = 3.0 × 10−4
and 5.1 × 10−4 s−1) (Fig. 3C).
Several lines of evidence show that the interaction
between non-specific IgM and VAR2CSA-type PfEMP1
involves the Cμ4 domain of IgM and the C-terminal DBL
domains in that type of PfEMP1 (Rasti et al., 2006;
Semblat et al., 2006; Czajkowsky et al., 2010; Barfod
et al., 2011). We found that antibodies specific for the IgM
Cμ4 domain (and to a lesser extent Cμ3) inhibited binding
of IgM to HB3VAR06+ IEs (Fig. 3D) and to FV6 (Fig. 3E).
This finding corresponds with previous data regarding
Fc-mediated IgM binding to other PfEMP1 proteins
(Ghumra et al., 2008; Barfod et al., 2011). The site for
Fc-mediated IgM binding in HB3VAR06 was identified in
experiments with recombinant single-, double- and triple-
domain constructs, which demonstrated that non-specific
IgM only bound to constructs containing DBLζ2
(domain D8) (Fig. 3F). In agreement with this, incubation
of HB3VAR06+ IEs with antisera to the two C-terminal
HB3VAR06 domains D8 and D9 strongly inhibited the
ability of non-specific IgM to bind to the IEs, whereas the
effect of the remaining HB3VAR06-specific antisera was
limited and decreased with increasing distance from D8
(Fig. 3F).
Fig. 2. HB3VAR06-positive P. falciparum parasites. Fluorescence
micrograph of rosette around an erythrocyte infected by in
vitro-selected P. falciparum HB3. Error bar: 5 μm (A). Labelling of
HB3VAR06+ IEs by antisera raised against different HB3VAR06
recombinant constructs measured by flow cytometry. Domains
included in the constructs used for immunization are shown in
brackets and background labelling (pre-immunization sera) is
shown by grey shading. Colour coding corresponds to that used in
Fig. 1A, except for multidomain constructs including several domain
subtypes (shown as black outlines) (B–J). Transcription profile of
var genes in P. falciparum HB3 selected in vitro for expression of
HB3VAR06 measured by quantitative real-time PCR (K).
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Fc-mediated IgM binding to HB3VAR06 and
immune evasion
Based on the structural similarity of the interaction
between non-specific IgM on the one hand and
HB3VAR06 and VAR2CSA-type PfEMP1 on the other, we
proceeded to examine the possibility of a correspond-
ing functional similarity. We previously reported that
Fc-mediated IgM binding to VAR2CSA-type PfEMP1 has
an immune-evasive function as it interferes with antigen-
specific IgG recognition and inhibition of phagocytosis of
IgG-opsonized IEs (Barfod et al., 2011). Incubation of
HB3VAR06+ IEs with IgM had no effect on the ability
of IgG in FV6-specific antiserum (Fig. 4A, leftmost bar) or
in EHP (Fig. 4A, rightmost bar) to label the IEs. Antisera to
the N-terminal half (D1–D5) of HB3VAR06 were similarly
unaffected by pre-incubation with IgM, whereas IE reac-
tivity of antisera to domains further downstream were
increasingly inhibited by IgM incubation (Fig. 4A). These
findings agreed well with the data pointing to DBLζ2 (D8)
as the site for Fc-mediated binding of IgM to HB3VAR06.
The reciprocal ability of antigen-specific IgG and non-
specific IgM to interfere with each other (Fig. 3F–G) sug-
gests that they have comparable binding affinities for
HB3VAR06, similar to previous reports for VAR2CSA-
type PfEMP1 (Barfod et al., 2011). However, the data in
Fig. 4A indicate that IgM would not efficiently inhibit
phagocytosis of IgG-opsonized HB3VAR06+ IEs because
of its inability to shield N-terminal IgG epitopes. This was
confirmed experimentally as non-specific IgM did not
Fig. 3. Binding of non-specific IgM to HB3VAR06. Binding of
non-specific IgM and FV6-specific antiserum to HB3-infected IEs
selected for expression of HB3VAR06 measured by flow cytometry
of magnet-purified late stage P. falciparum HB3-infected
erythrocytes (A). Binding of IgM to recombinant full-length proteins
representing HB3VAR06 (FV6), IT4VAR04 (FV2) and IT4VAR13
(FV13), respectively, measured by ELISA (B). Affinity of IgM for
FV6 (left) and FV2 (right) measured by SPR. The SPR sensorgram
data (black) and fits (grey) at five concentrations [1.125 (bottom
trace); 2.25, 4.5, 9 and 18 nM (top trace)] are shown (C).
Interference of non-specific IgA and monoclonal antibodies specific
for Cμ2 (HB57), Cμ3 (5D7) or Cμ4 (1G6) with IgM binding to
HB3VAR06+ IEs measured by flow cytometry (D). Interference of
IgA and monoclonal antibodies specific for Cμ2 (HB57), Cμ3 (5D7)
or Cμ4 (1G6) with IgM binding to recombinant full-length
HB3VAR06 measured by ELISA (E). Binding of IgM to recombinant
HB3VAR06 single-, double- and triple-domain constructs relative to
IgM binding to FV6 measured by ELISA (F). Interference with IgM
binding to HB3VAR06+ IEs by antisera raised against recombinant
HB3VAR06 single- and double-domain constructs measured by
flow cytometry (G). Means and standard deviation and values
statistically significant different (*P < 0.05; **P < 0.01; ***P < 0.001)
from control values in the leftmost bar of each panel are shown (B,
D–G). Control values were results obtained in the absence of any
IgM inhibitor (D and E) using FV6 as the coating antigen (F) or in
the presence of pre-immunization serum (G). All experiments were
repeated at least three times with similar results.
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reduce phagocytosis of HB3VAR06+ IEs opsonized by
FV6-specific antiserum (Fig. 4B). Similarly, the effect of
IgM on IEs opsonized by human immune plasma was
small [25% (95% confidence interval: 8–42%)] and not
different from that obtained with non-specific IgA, which
does not bind to HB3VAR06 (Fig. 4C). Finally, the IgM/IgG
competition data (Fig. 3F–G) would be consistent with
HB3VAR06 having an elongated, rod-like structure
causing the observed simple relationship between IgG
epitope and IgM binding site proximity on the one hand,
and shielding capacity of non-specific IgM on the
other. We confirmed this prediction by small-angle X-ray
spectrometry (SAXS) analysis of FV6 (Fig. 5A, Supple-
mentary Fig. S1, Table 1) yielding a low-resolution struc-
ture and statistics similar to those obtained with the
elongated FV13 (Brown et al., 2013) but different from
those of the globular FV2 (Srivastava et al., 2010;
Clausen et al., 2012). Additional SAXS analysis of
N-terminal (D1-D3) and C-terminal (D7-D9) HB3VAR06
constructs (Fig. 5A) allowed orientation of the molecular
SAXS envelope of FV6.
Fc-mediated IgM binding to HB3VAR06 and rosetting
Rosetting is a highly variable phenotype, which depends
on serum factors in some cases but not in others
(Mercereau-Puijalon et al., 2008). The factors involved in
serum-dependent rosetting have not been unequivocally
identified, although IgM has been repeatedly implicated
(Scholander et al., 1996; Clough et al., 1998; Somner
et al., 2000; Rowe et al., 2002; Luginbuhl et al., 2007). We
could confirm that serum and IgM is indeed required for
rosetting of HB3VAR06+ IEs. Thus, rosetting did not occur
in serum-free Albumax-containing culture medium and
depletion of IgM abolished rosetting in serum-containing
medium (Fig. 5B). Rosetting was fully restored when
exogenous IgM was added back to IgM-depleted serum,
whereas addition of exogenous IgM to Albumax medium
had no effect (Fig. 5B). Thus, IgM appears to be neces-
sary but is not in itself sufficient for rosette formation in
P. falciparum HB3 expressing HB3VAR06.
As IgM binds near the C-terminal, membrane-proximal
end of HB3VAR06 opposite the erythrocyte-binding
N-terminal head structure, the effect of non-specific IgM
on rosetting could be indirect and related to its pentameric
structure. Indeed, previous studies have shown that only
intact IgM augments rosetting (Scholander et al., 1996;
Somner et al., 2000; Ghumra et al., 2008). We therefore
assessed the stoichiometry of the IgM–Fv6 interaction via
analytical ultracentrifugation. Our experiments showed
that FV6 existed predominantly as a monomer with a
sedimentation coefficient of 10.5 S (Fig. 5C). Pentameric
IgM was found to have a sedimentation coefficient of
18.5 S (Fig. 5C) in agreement with the literature (Miller
and Metzger, 1966). Ultracentrifugation of FV6 and IgM
Fig. 4. Non-specific antibody interference with opsonization and
phagocytosis. Interference with HB3VAR06 domain-specific IgG
recognition of HB3VAR06+ IEs by non-specific IgM measured by
flow cytometry (A). Phagocytosis of IEs opsonized by FV6-specific
antiserum (B) or human immune plasma (C) after or without
pre-incubation of IEs with non-specific IgM or IgA measured by flow
cytometry. Means and standard deviation, and statistically
significant values (*P < 0.05; **P < 0.01; ***P < 0.001) relative to
results obtained with pre-immunization serum (A) or without IgM
pre-incubation (B and C) are shown.
Table 1. Basic SAXS analysis statistics.
MWProtein (kD) MWI(0) (kD) Rg (nm) Dmax (nm) I(0)measured I(0)theoretical
FV6 (D1-D9) 345 366 9.1 34.8 1.38 1.10
D1-D4 85 84 4.0 14.1 0.124 0.11
D7-D9 133 120 5.4 19.0 0.123 0.14
Theoretical molecular masses (MWProtein) are based on the amino acid sequences of recombinant protein constructs. SAXS-derived molecular
masses [MWI(0)] were calculated from the obtained scattering intensity [I(0)]. Particle radius of gyration (Rg) calculations on Guinier analysis of the
scattering data. Maximum particle size values (Dmax) were obtained from the derived pair–distance distribution functions. The theoretical I(0) was
calculated from the amino acid sequence and protein concentration.
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mixed at equimolar (1:1) concentration yielded a single
peak at 23.5 S, indicating that all FV6 and IgM were
bound to each other and formed a single, larger complex.
When FV6 was added in molar excess of IgM (2:1 and
3:1), two main peaks were evident, one at 26 S corre-
sponding to two FV6 molecules bound to a single IgM
molecule (2:1 complex) and one corresponding to free
FV6. More unbound FV6 was seen in the 9S peak at the
3:1 than the 2:1 ratio, indicating that the IgM molecules
could not accommodate more than two FV6 each (2:1
complex). Small additional peaks above 36 S were inter-
preted as aggregated species.
Both ends of HB3VAR06 are required for rosetting
Ghumra et al. (2008) have documented the involvement
of the N-terminal head structure of HB3VAR06 in
rosetting. To verify that finding, and to examine the
involvement of the IgM-binding DBL domain near the
C-terminus of the molecule, we assayed the effect of
HB3VAR06 domain-specific antisera on rosetting. We
found that antisera specific for domains at the N-terminus
of HB3VAR06 (domains D1-D4) as well as the C-terminal
domains D7 and D8 inhibited rosette formation, whereas
antisera to the central domains D5 and D6 did not. Thus,
epitopes at both the N- and the C-terminus of this PfEMP1
are necessary for rosetting.
Discussion
In this study, we provide a multi-approach analysis
of the molecular details and functional significance of
Fc-dependent binding of IgM to a PfEMP1 involved in
rosetting. The formation of rosettes of uninfected erythro-
cytes around P. falciparum IEs is a conspicuous and well-
recognized phenotype mediated by PfEMP1 (Chen et al.,
1998) that has been repeatedly associated with severe
malaria (reviewed by Mercereau-Puijalon et al., 2008).
We used HB3VAR06, previously identified as the
Fig. 5. The three-dimensional conformation of HB3VAR06, IgM
dependency of rosetting and stoichiometry of the FV6:IgM
interaction. SAXS modelling of the envelopes of FV6 (blue), the
N-terminal domains D1–D3 (green) and the C-terminal domains
D7–D9 (red) as seen from four different angles. The relative point
of view in each panel is indicated by arrows in the bottom left panel
corner (A). Rosetting rates of HBVAR06+ IEs in culture medium
supplemented with non-immune human serum (NHS), IgM-depleted
NHS (dNHS), dNHS plus IgM (dNHS + IgM), Albumax or Albumax
plus IgM (Albumax + IgM) are presented as in Fig. 3 (B). Analytical
ultracentrifugation of recombinant full-length HB3VAR06 (FV6; blue)
or IgM (IgM; grey), and of FV6 and IgM together at molar ratios of
1:1 (red), 2:1 (green) and 3:1(black) (C). Rosetting rates of
HBVAR06+ IEs in the presence of HB3VAR06 domain-specific
antisera or pre-immunization serum (Ctrl), relative to rosetting in
NHS. Data presented as in Fig. 3G (D).
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dominant PfEMP1 protein expressed by P. falciparum
HB3 selected for IgM-dependent rosetting (Ghumra et al.,
2012). We first generated a series of recombinant single-
domain, multiple-domain and full-length constructs repre-
senting HB3VAR06 (Fig. 1). Following repeated selection
of IEs with corresponding antisera, the HB3VAR06-
encoding gene hb3var06 was the predominant var gene
transcribed by the parasites, and the large majority of IEs
formed rosettes and was labelled by each of the
HB3VAR06-specific antisera and bound non-specific IgM
(Figs 2 and 3A). Recombinant full-length HB3VAR06
(FV6) bound IgM to the same extent (Fig. 3B) as the
VAR2CSA-type PfEMP1 that are involved in placental
sequestration of IEs but do not mediate the formation of
rosettes (Creasey et al., 2003; Salanti et al., 2003; 2004;
Rasti et al., 2006). The affinity of the interaction between
FV6 and IgM (Fig. 3C) was in the same range as those
reported for the interaction between other full-length
PfEMP1 proteins and their cognate receptors (Khunrae
et al., 2010; Srivastava et al., 2010; Brown et al., 2013).
This high-affinity interaction between individual FV6 mol-
ecules in solution and immobilized IgM effectively rules
out the previously suggested theory that only pentameric
IgM supports rosetting because it is required to overcome
an inherently low affinity between IgM and DBL domains
in PfEMP1 (Scholander et al., 1996; Ghumra et al., 2008).
The interaction between IgM and HB3VAR06 involved
Cμ4 in IgM and the penultimate DBLζ2 domain at the
C-terminus of HB3VAR06 (Fig. 3D–G). This is very similar
to what has been reported previously for VAR2CSA-type
PfEMP1 and for another rosette-mediating PfEMP1
protein, TM284VAR1 (Rasti et al., 2006; Semblat et al.,
2006; Ghumra et al., 2008; Czajkowsky et al., 2010;
Barfod et al., 2011).
At the outset of the present study, the functional signifi-
cance of the interaction of HB3VAR06 with IgM remained
unclear. We therefore initially hypothesized that binding of
non-specific IgM to rosetting PfEMP1 might shield IEs
from specific IgG recognition and phagocytosis as
reported for IEs expressing VAR2CSA-type PfEMP1
(Barfod et al., 2011), as well as in other host–parasite
systems (Garcia et al., 1997; Echaide et al., 1998). Alter-
natively, or in addition, the IgM might act as ‘bridges’
between the central IE and the surrounding erythrocytes
in rosettes (Scholander et al., 1996). However, we found
that non-specific IgM binding to HB3VAR06 was inefficient
in inhibiting IgG recognition of HB3VAR06 and
phagocytosis of IgG-opsonized IEs, except in the case of
IgG specific for epitopes near the IgM binding site in the
DBLζ2 domain of this PfEMP1 (Fig. 4). The inability of
non-specific IgM to shield HB3VAR06 from specific IgG
recognition agrees with our demonstration that this
PfEMP1 has an elongated, rod-like structure (Fig. 5A)
similar to that of the ICAM-1-binding PfEMP1 protein
IT4VAR13 (Brown et al., 2013). A Kratky plot of the
FV6 SAXS data (Supplementary Fig. S1C) furthermore
indicated that the HB3VAR06 ectodomain is rigid as
reported for other PfEMP1 molecules (Brown et al., 2013;
Higgins and Carrington, 2014). This is the first structural
description of a full-length PfEMP1 protein mediating
rosetting, and it provides a plausible explanation for the
divergent functional consequences of IgM binding to
HB3VAR06 and the much more globular VAR2CSA-type
PfEMP1.
HB3VAR06-dependent rosetting was found to require
non-specific IgM (Fig. 5B) binding to HB3VAR06 at the
C-terminal end of the PfEMP1 (Fig. 3F–G). In contrast,
the interaction with the surrounding erythrocytes
involves the N-terminal head structure (Rowe et al.,
1997; Chen et al., 2000; Ghumra et al., 2012) at the
opposite end of this extended molecule that is more than
30 nm long (Table 1). Together, these observations make
it unlikely that IgM can act as ‘bridges’ between the
IE and the surrounding erythrocytes in a rosette
(Scholander et al., 1996), unless additional and so far
unidentified components are involved. This latter possi-
bility would be consistent with earlier evidence
(Scholander et al., 1998; Somner et al., 2000) and our
finding that addition of purified non-specific IgM to
serum-free medium did not lead to rosette formation
(Fig. 5B). In any case, our evidence demonstrates the
rosetting mediated by HB3VAR06 involves structural ele-
ments at both the N- and the C-terminal ends of this
PfEMP1 (Fig. 5D).
Based on the above findings, and the fact that only
pentameric IgM can support rosetting (Scholander et al.,
1996; Somner et al., 2000; Ghumra et al., 2008), we
therefore speculated that the function of IgM in rosetting
might instead be to facilitate coordinated interaction of
multiple PfEMP1 head structures with their receptors on
adjacent erythrocytes (Rowe et al., 1995; Barragan et al.,
2000a,b; Vogt et al., 2004). Although rosetting is a highly
variable phenotype, rosettes can consistently be dis-
rupted by sulfated glycosaminoglycans (Carlson and
Wahlgren, 1992; Rowe et al., 1994; Barragan et al.,
1999), whereas they can form even after pretreatment of
the uninfected erythrocytes by protease (Rowe et al.,
1994). This suggests that rosetting PfEMP1 proteins inter-
act mainly with carbohydrate moieties on the surrounding
erythrocytes. The affinity of the rosetting PfEMP1 VarO
head structure for blood group trisaccharides has previ-
ously been found to be in the micromolar range
(Vigan-Womas et al., 2012), and coordinated interaction
involving multiple well-aligned and knob-associated
PfEMP1 molecules might therefore be required to
increase avidity sufficiently for rosetting to occur. It is not
known how many PfEMP1 molecules are expressed per
knob, but theoretical estimates are in the 10–100 range
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(Joergensen et al., 2010b), and alignment of these
PfEMP1 molecules would potentially greatly increase
their combined avidity for host receptors. Such a function
would resemble that proposed for the malaria parasite
proteins P. falciparum erythrocyte-binding antigen-175
and P. vivax Duffy binding protein (Tolia et al., 2005;
Batchelor et al., 2011; 2014; Wanaguru et al., 2013). In
those, DBL domains form homo-dimers when binding to
their host receptors presumably to enhance receptor
affinity and specificity, thereby facilitating erythrocyte
invasion. Although the parasite molecule and mechanism
we propose here differ from that already demonstrated
for merozoite-expressed adhesins, the concept of
multimerization to increase avidity for erythrocyte
receptors is a mechanism already employed by malaria
parasites.
In conclusion, our study provides comprehensive new
evidence on the molecular details and functional signifi-
cance of Fc-dependent IgM binding in rosetting, which is
a long-recognized marker of parasites causing severe
P. falciparum malaria. The interaction between non-
specific IgM and the rosette-mediating PfEMP1 protein
HB3VAR06 involves the same Fc domains in IgM as
those interacting with VAR2CSA-type PfEMP1. Never-
theless, the function appears to be markedly different as
Fc-dependent IgM binding in rosetting does not protect
the parasite from phagocytosis and is required for para-
site adhesion. Furthermore, our data suggest that the
influence of IgM on rosetting is related to its capacity to
bind multiple PfEMP1 proteins, potentially increasing the
combined avidity of multiple PfEMP1 proteins for eryth-
rocyte carbohydrate receptors. We cannot formally rule
out that IgM can form ‘bridges’ between IEs and
surrounding erythrocytes, but our data suggest that
structural limitations would make this unlikely at least
for IgM alone. The identity and role of additional serum
proteins in HB3VAR06-mediated rosetting, such as
fibrinogen, albumin, von Willebrand factor and TSP,
which have all previously been implicated in rosetting
(Treutiger et al., 1999) remain an open question requir-
ing further study.
Experimental procedures
Ethics statement
The collection of human plasma samples was approved by the
Institutional Review Board of Noguchi Memorial Institute for
Medical Research, University of Ghana (Study Number 038/10-
11), and by the Regional Research Ethics Committees, Capital
Region of Denmark (Protocol H-4-2013-083). All donors were
adults and provided written informed consent. All the animal
experiments were conducted according to Danish Law and
approved (permit 2012-15-2934-00567) by the Danish Animal
Procedures Committee (‘Dyreforsøgstilsynet’).
Recombinant parasite proteins
The entire ectodomain of the PfEMP1 protein HB3VAR06 (FV6)
was codon optimized (GenBank accession number KP203835)
for insect cell expression by GeneArt (Regensburg, Germany).
Single-, double-, triple-domain and full-length constructs were
cloned into the transfer vector pAcGP67-A (BD Biosciences, San
Jose, CA, USA) with a C-terminal hexa-histidine tag. The transfer
vector was then co-transfected with linearized BakPak6
Baculovirus DNA (BD Biosciences) into Sf9 insect cells to gen-
erate recombinant virus particles. Secreted proteins were purified
from the supernatants of transfected high-five insect cells using
Ni2+ metal chelate agarose HisTrap HP columns (GE Healthcare,
Fairfield, CT, USA) followed by dialysis of eluates (20 mM
Na2PO4, 500 mM NaCl, pH 7.2). Proteins used for analysis by
SPR, analytical ultra-centrifugation or small-angle X-ray spec-
trometry (SAXS) were further purified on Superdex 200 16/60
size exclusion chromatography columns (GE Healthcare).
Domain boundaries for all the recombinant HB3VAR06 con-
structs are shown in Fig. 1. Two other recombinant full-length
PfEMP1 proteins described previously, IT4VAR13 (FV13; ref.
Brown et al., 2013) and the VAR2CSA-type PfEMP1 protein
IT4VAR04 (FV2; ref. Khunrae et al., 2010), were included as
control antigens.
Animal antisera and human plasma
Antisera specific for recombinant HB3VAR06 constructs were
generated by subcutaneous immunization of rats (20 μg antigen
in Freund’s complete adjuvant followed by 20 μg in Freund’s
incomplete adjuvant 21 and 42 days later) and rabbits (50 μg
antigen in Freund’s complete adjuvant followed by 50 μg in
Freund’s incomplete adjuvant 28, 49 and 63 days later). One
(FV6) or two (all other constructs) animals were used per con-
struct for immunization. Antisera were collected on day 49 (rats)
or 70 (rabbits), pooled and depleted of non-specific O Rh+ eryth-
rocyte reactivity. Pre-immunization serum was used as negative
control. Mouse monoclonal antibodies specific for human Fcμ2,
Fcμ3 and Fcμ4 (described by Rudich et al., 1985) were a kind gift
from Patricia Mongini.
Pooled plasma from 10 anonymous healthy, P. falciparum-
exposed adults (exposed human plasma; EHP) or pooled serum
from non-exposed blood bank donors; NHS) was used with or
without IgM depletion by incubation with biotinylated donkey anti-
human IgM-Fcμ5 (Jackson ImmunoResearch) coupled to
streptavidin-conjugated Dynabeads (MyOne T1, 8 mg; Life Tech-
nologies). Absence of IgM after depletion was confirmed by
immunoblotting with horse radish peroxidase-conjugated rabbit
anti-human IgM (1:1000; Dako).
Measurements of IgM- and antigen-specific IgG binding
to PfEMP1
Binding of IgM to recombinant HB3VAR06 constructs was quan-
tified by ELISA. Flat-bottomed 96-well MaxiSorp plates (Thermo
Scientific) were coated overnight with recombinant protein
(18 nM, 4°C) in Tris saline magnesium (TSM) buffer (20 mM Tris,
150 mM NaCl, 2 mM CaCl2, 2 mM MgCl2, pH 7.4), blocked [2 h,
room temperature (RT)] with TSMB (TSM buffer with 1% Ig-free
BSA and 0.05% Tween-20), washed with TSM buffer supple-
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mented with 0.05% Tween-20 and incubated (2 h, RT) with puri-
fied human IgM (Sigma; I8260; 10 nM in TSMB buffer). After
washing away unbound antibody, IgM was detected using rabbit
anti-human IgM HRP (Dako; P215, 1:1000 in TSMB buffer). After
washing unbound secondary antibody, bound HRP was reacted
with OPD (Dako; S2045) according to manufacturer’s instructions
and absorbance detected (492 nm). In assays to determine
which Fc domains were involved in IgM binding to HB3VAR06,
IgM (10 nM) was pre-incubated overnight (4°C) with mouse anti-
human Fcμ domain-specific monoclonal antibodies or IgA (IgA
(Sigma; L1010; 100 nM) in TSMB buffer.
The binding of IgM and antigen-specific IgG to IEs was
detected by flow cytometry essentially as described (Barfod
et al., 2011). In brief, late-stage IEs were purified by magnet-
activated cell sorting (MACS) and labelled (1 × 105 IEs, 30 min,
RT) first with non-specific IgM (10 nM), then rat or rabbit antisera
or EHP (1:20), and finally appropriate secondary antibody
(donkey anti-human IgM-PE (Jackson ImmunoResearch; 709-
116-073; 1:400), goat anti-rat IgG-FITC (Life Technologies; clone
62-9511; 1:150), goat anti-rabbit IgG-FITC (Vector; clone
FI-1000; 1:150) and ethidium bromide (2 μg ml−1). In some
assays, the antibody order was reversed, i.e. first antisera or
EHP, then IgM. In antibody competition assays, the competing
antibodies were applied in separate steps. In experiments
assessing IE surface labelling by non-specific IgM and antigen-
specific IgG at the same time, the donkey anti-human IgM-PE
and donkey anti-rabbit PerCP (Jackson; 711-126-152; 1:50) were
used as secondary antibody reagents and ethidium bromide was
omitted. IEs were washed three times between incubation with
primary and secondary antibody. Antibody surface labelling of IEs
was quantified by flow cytometry using a Beckman Coulter
FC500 instrument (Beckman Coulter) followed by analysis of list
mode data files using FlowJo software v.7.6 (Treestar).
Malaria parasite cultivation and in vitro
selection procedures
Plasmodium falciparum HB3 parasites (Bhasin and Trager, 1984)
were grown in vitro in O Rh+ erythrocytes using AlbuMax II (Life
Technologies)-supplemented Roswell Park Memorial Institute
(RPMI) medium and a controlled atmosphere, essentially as
described (Cranmer et al., 1997). IEs were selected for rosetting
using sedimentation in gelatin two times per week as described
(Handunnetti et al., 1992) and for surface expression of
HB3VAR06 by immuno-magnetic selection once every 1–2
weeks using HB3VAR06-specific antisera and protein A-coupled
DynaBeads as described (Staalsoe et al., 2003). Cultures were
kept synchronous by sorbitol treatment twice weekly as
described (Moll et al., 2008). The genotypic identity of the para-
sites and absence of Mycoplasma contamination was verified
regularly as described (Bengtsson et al., 2013).
Var gene transcription analysis
Plasmodium falciparum RNA was prepared from ring stage IEs,
reverse-transcribed and used to determine the relative propor-
tions of individual var gene transcripts by quantitative real-time
PCR as described in detail elsewhere (Joergensen et al., 2010a)
using real-time PCR-optimized, gene-specific primers (20 μM) for
each of the var genes in the P. falciparum HB3 genome (Soerli
et al., 2009).
Rosetting assay
Rosetting assays were performed using cultures with high
rosetting rates (60–95%) and frequencies were assessed by
counting 200 ethidium bromide-stained IEs and noting those that
had two or more erythrocytes adhering using wet slide prepara-
tions and fluorescence microscopy. To determine the role of
Fc-mediated IgM binding in rosetting, synchronous ring stage IEs
were incubated overnight (37°C, 5% CO2) with NHS (10%), IgM-
depleted NHS, IgM-depleted NHS plus human IgM (Sigma;
4 mg ml−1), Albumax II (10%) or Albumax II (10%) plus IgM
(4 mg ml−1). The following day the relative rosetting frequency of
triplicate wells was assessed as described above. To examine
the involvement of different HB3VAR06 domains in rosetting,
synchronous HB3VAR06+ IEs were grown from the ring to the late
trophozoite stages in 10% NHS in the presence of 1:20 dilutions
of domain-specific antisera followed by assessment of rosetting
rates as above.
SPR assay
We used a Biacore 2000 (GE Healthcare) for affinity measure-
ments by SPR. All experiments were performed in N-[2-
hydroxyethyl]piperazine-N′-[2-ethanesulfonic acid] (HEPES)
buffer [0.01 M HEPES, 0.15 M NaCl, 3 mM ethylenedia-
minetetraacetic acid (EDTA), 0.005% v/v Surfactant P20] at
pH 7.4 and 20°C. FV6 or FV2 were flowed over (50 ml min−1 for
60 s followed by buffer for 120 s) IgM (750 RU) immobilized on a
CM4 biosensor chip (GE Healthcare) by amine coupling. After
each run, the chip was regenerated (1 M NaCl). Specific binding
response to IgM was calculated by subtracting the response
to an uncoupled chip and to a buffer injection. The kinetic
sensorgrams were fitted to a global 1:1 interaction model to allow
calculation of ka, kd and KD using BIAevaluation software v.4.1
(GE Healthcare).
Phagocytosis assay
Phagocytosis of antibody-opsonized IEs was measured as
described previously (Tippett et al., 2007). In brief, MACS-
purified late-stage IEs were opsonized with FV6 antiserum or
human immune-serum (1:20 dilution, 30 min, RT), washed in
PBS with 2% FBS (PBS2), labelled with ethidium bromide
(0.1 mg ml−1, 10 min, RT), washed four times in PBS2 and
resuspended in RPMI supplemented with 2% FCS. Human
monocytic leukaemia line THP-1 cells (TIB-202; LGC Standards)
(4 × 105 per well) and IEs (2 × 105 per well) were incubated
(30 min, 37°C, 5% CO2) in 96-well plates (Corning; 113 135 95).
Non-phagocytosed IEs were lysed (15 mM NH4Cl, 10 mM
NaHCO3, 1 mM EDTA, 3 min), and phagocytosis assessed by
flow cytometry as above. In some experiments, IEs were pre-
incubated with 10 nM IgM or IgA before addition of anti- or
immune-serum.
SAXS
SAXS data on recombinant HB3VAR06 constructs were collected
at the P12 BioSAXS beam line (PETRAIII). The beam line was
equipped with a PILATUS 2M detector set 3.1 m from the sample
using a 0.13–0.14 nm beam wavelength. Concentration series of
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different constructs were prepared in order to eliminate structure
factor effects. All measurements were performed at 10°C, col-
lecting 20 frames of 0.05 s exposure time of each construct. The
pair distance distribution function [P(r)] was obtained by indirect
Fourier transformation of the scattering data giving the estimated
radius of gyration (Rg) and maximum particle dimension (Dmax)
(Svergun, 1992). For each construct, 20 ab initio bead models
were generated from the scattering data using online DAMMIF
(Franke and Svergun, 2009). The final models were created by
averaging and filtering the 20 constructs using DAMAVER and
DAMFILT (Volkov and Svergun, 2003).
Analytical ultracentrifugation
Sedimentation velocity experiments were conducted using a
Beckman Optima XL-I analytical ultracentrifuge (Beckman
Coulter) (40 000 r.p.m., 20°C). All the size exclusion
chromatography-purified protein samples were prepared in a
PBS buffer (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4,
1.8 mM KH2PO4). Reference and sample were loaded into a
double-sector centrepiece and mounted in a Beckman An-60 Ti
rotor. Results from multiple scans (monitored at 280 nm) at molar
ratios 1:1, 1:2 and 1:3 of IgM and FV6 (where the IgM concen-
tration was kept constant at 0.2 μM to give an absorbance of
0.296 in a 1.2 cm path length) were fitted to a continuous size
distribution using SEDFIT v.14.1 software (Schuck, 2000).
Solvent density (1.00564 g ml−1), viscosity (0.01020 P) and
the partial-specific volumes of IgM (0.727 cm3 g−1) and FV6
(0.727 cm3 g−1) were calculated using SEDNTERP software
(v.20120828) (Laue et al., 1992).
Statistical analyses
All experiments were performed at least three times with similar
results. Summary data in Figs 3–5 are reported as the overall
means and standard deviations of all experiments performed
expressed as a percentage of the relevant experimental control
data. The statistical significance levels reported in Fig. 3D–G,
Fig. 4B–C, Fig. 5B and Fig. 5D were obtained by one-way
analysis of variance followed by Holm–Sidak post hoc test to
identify groups significantly different from the indicated control
group. The data presented in Fig. 4A were analysed by Stu-
dent’s t-test.
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Fig. S1. SAXS analysis of HB3VAR06. Theoretical scattering
curves calculated from ab initio reconstructions (lines) and
experimental scattering data (points and error bars) (A) and dis-
tance distribution functions (B) for full-length HB3VAR06 (FV6,
blue), the N-terminal domains D1–D4 (red) and the C-terminal
domains D7–D9 (green) (B). The P(r) functions were calculated
from the scattering intensity I(q). Kratky plot of full-length
HB3VAR06 (FV6) (C).
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